- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: panobinostat (DACi)
Total 154 results
-
M.D. Anderson Cancer CenterWithdrawn
-
Dana-Farber Cancer InstituteNovartis; Brigham and Women's HospitalCompletedMelanoma | Malignant MelanomaUnited States
-
University of California, San FranciscoNational Cancer Institute (NCI)CompletedUnspecified Adult Solid Tumor, Protocol SpecificUnited States
-
Patrick Y. Wen, MDMassachusetts General Hospital; Northwestern University; Novartis; Beth Israel... and other collaboratorsCompleted
-
Tulane University Health Sciences CenterNovartis; Board of Regents, State of LouisianaWithdrawnBreast CancerUnited States
-
Medical University of South CarolinaNovartis PharmaceuticalsCompletedSoft Tissue Sarcoma | Renal Cancer | Non Small Cell Lung Cancer (NSCLC)United States
-
Novartis PharmaceuticalsCompletedAcute Myelogenous Leukemia | Refractory LeukemiaBelgium, Korea, Republic of, Turkey, Germany, Australia, France, Switzerland, United Kingdom, Spain, Italy, Peru, United States
-
Roswell Park Cancer InstituteNovartisTerminatedHodgkin's Lymphoma | Non-Hodgkin's LymphomaUnited States
-
Sidney Kimmel Cancer Center at Thomas Jefferson...NovartisTerminatedBrain Metastasis | Recurrent Glioma | High-grade MeningiomaUnited States
-
Anne Beaven, MDNovartisTerminatedDiffuse Large B-cell LymphomaUnited States
-
Novartis PharmaceuticalsWithdrawn
-
Washington University School of MedicineCompletedMyelodysplastic Syndromes | Leukemia, Myeloid, AcuteUnited States
-
Translational Research in OncologyCompletedBreast CancerUnited States
-
Novartis PharmaceuticalsCompletedHodgkin's LymphomaUnited States, Belgium, Germany, Canada, Singapore, Netherlands, France, Australia, Russian Federation, Israel, Brazil, Italy, New Zealand, Poland
-
Novartis PharmaceuticalsTerminatedBreast CancerFrance, Canada, United Kingdom, Germany, Italy, United States
-
Novartis PharmaceuticalsNo longer availableMultiple MyelomaUnited States
-
Translational Research in OncologyTerminated
-
Therapeutic Advances in Childhood Leukemia ConsortiumNovartisCompletedNon-Hodgkin's Lymphoma | Lymphoblastic Leukemia, Acute, Childhood | Hodgkin's Disease | Myelogenous Leukemia, Acute, ChildhoodUnited States
-
University of PittsburghNovartis PharmaceuticalsTerminatedNon-Small Cell Lung CancerUnited States
-
Prof Jamie CavenaghNovartis; Myeloma UKUnknownMultiple MyelomaUnited Kingdom
-
SCRI Development Innovations, LLCNovartisCompletedBreast CancerUnited States
-
University of Southern CaliforniaNovartisTerminatedStage IV Colon Cancer | Stage IV Rectal Cancer | Recurrent Colon Cancer | Recurrent Rectal CancerUnited States
-
Ronald HoffmanNovartisUnknownPrimary Myelofibrosis | Polycythemia Vera, Post-Polycythemic Myelofibrosis Phase | Post-Essential Thrombocythemia Related MyelofibrosisUnited States
-
M.D. Anderson Cancer CenterNovartisCompleted
-
University of ArkansasNovartisTerminated
-
H. Lee Moffitt Cancer Center and Research InstituteNovartis; Genentech, Inc.CompletedHead and Neck Cancer | Lung CancerUnited States
-
Emory UniversityNovartis; Eisai Inc.TerminatedBreast Cancer | Breast Neoplasms | Breast TumorsUnited States
-
Cancer Trials IrelandWithdrawn
-
Anand JillellaNovartis PharmaceuticalsCompletedMantle Cell LymphomaUnited States
-
City of Hope Medical CenterNational Cancer Institute (NCI)Terminated
-
City of Hope Medical CenterNational Cancer Institute (NCI)Completed
-
Singapore General HospitalCompletedAngioimmunoblastic T-cell Lymphoma | Hepatosplenic T-cell Lymphoma | Peripheral T-cell Lymphoma (Not Otherwise Specified) | Extranodal NK/T-cell Lymphoma Nasal Type | Enteropathy- Type T-cell Lymphoma | Anaplastic Large Cell Lymphoma (ALCL) (ALK-1 Negative) | Relapsed ALCL (ALK-1 Positive) Post...Singapore, Malaysia, Korea, Republic of
-
OncotherapeuticsNovartisCompletedMultiple MyelomaUnited States
-
University of AarhusMassachusetts General Hospital; Novartis; Aarhus University Hospital; Monash University and other collaboratorsCompleted
-
Armando Santoro, MDUnknown
-
H. Lee Moffitt Cancer Center and Research InstituteNovartis PharmaceuticalsTerminatedNon-Hodgkin's LymphomaUnited States
-
SCRI Development Innovations, LLCNovartisTerminated
-
Duke UniversityNovartisWithdrawn
-
Technical University of MunichNovartisTerminated
-
Centre Leon BerardCompleted
-
City of Hope Medical CenterNational Cancer Institute (NCI)CompletedLymphoma | Multiple Myeloma and Plasma Cell NeoplasmUnited States
-
SCRI Development Innovations, LLCNovartisWithdrawnChronic Graft-Versus-Host DiseaseUnited States
-
Deric M Park MDUnknown
-
Herbert HurwitzNovartis; Genentech, Inc.CompletedAdvanced Solid TumorsUnited States
-
Novartis PharmaceuticalsTerminatedLeukemia-Lymphoma, Adult T-Cell | Cutaneous T-Cell LymphomaJapan
-
NovartisCompletedCutaneous T-Cell Lymphoma | TumorsJapan
-
Novartis PharmaceuticalsCompletedCancer Patients With Advanced Solid Tumors Including Lymphoma or Chronic Hematological MalignanciesUnited States
-
Case Comprehensive Cancer CenterNational Cancer Institute (NCI)Terminated
-
Swedish Medical CenterNovartisCompleted
-
Southern Europe New Drug OrganizationNovartisUnknownAdvanced Solid TumorsSwitzerland